Diagnosis of sarcoidosis of the eyes; This spontaneous case was reported by a patient family member or friend and describes the occurrence of OCULAR SARCOIDOSIS (Diagnosis of sarcoidosis of the eyes) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21N and 045B21A) for COVID-19 vaccination.     Concurrent medical conditions included Anemic and Allergy to antibiotic (Bactrim).   On 03-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In September 2022, the patient experienced OCULAR SARCOIDOSIS (Diagnosis of sarcoidosis of the eyes) (seriousness criterion medically significant). At the time of the report, OCULAR SARCOIDOSIS (Diagnosis of sarcoidosis of the eyes) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2022, Biopsy: sarcoidosis of the eyes.         Concomitant product use    It was reported that patient experienced swelling of both eyes, hurting after the vaccine. The patient had nothing wrong until after she took the vaccines. The patient was referred to a rheumatologist. HCP thought it was an allergic reaction. They treated patient with unspecified steroid for what they thought was an allergic reaction, it went away, and came back. A biopsy was performed approximately three weeks prior to the report, received a confirmed diagnosis of sarcoidosis of the eyes. The patient would have this the rest of her life because there is no cure for this.  Company Comment: This is a spontaneous case concerning  a  29-year-old, female patient with no relevant medical history, who experienced the unexpected serious (medically significant) event of ocular Sarcodosis. The exact date of the event was not specified, hence latency could not be assessed. It was reported that patient experienced swelling of both eyes, after the vaccine. The patient had nothing wrong until after she took the vaccines. The patient was referred to a rheumatologist. HCP thought it was an allergic reaction. They treated patient with unspecified steroid for what they thought was an allergic reaction, it went away, and came back. A biopsy was performed approximately three weeks prior to the report, received a confirmed diagnosis of sarcoidosis of the eyes. No further details on clinical course, lab test results and treatment received were reported. Outcome of the event had not resolved at the time of report. The benefit-risk relationship of mRNA-1273 Vaccine, is not affected by this report.; Sender's Comments: This is a spontaneous case concerning  a  29-year-old, female patient with no relevant medical history, who experienced the unexpected serious (medically significant) event of ocular Sarcodosis. The exact date of the event was not specified, hence latency could not be assessed. It was reported that patient experienced swelling of both eyes, after the vaccine. The patient had nothing wrong until after she took the vaccines. The patient was referred to a rheumatologist. HCP thought it was an allergic reaction. They treated patient with unspecified steroid for what they thought was an allergic reaction, it went away, and came back. A biopsy was performed approximately three weeks prior to the report, received a confirmed diagnosis of sarcoidosis of the eyes. No further details on clinical course, lab test results and treatment received were reported. Outcome of the event had not resolved at the time of report. The benefit-risk relationship of mRNA-1273 Vaccine, is not affected by this report.